These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36969467)

  • 1. Process Intensification of a Napabucasin Manufacturing Method Utilizing Microflow Chemistry.
    Usutani H; Yamamoto K; Hashimoto K
    ACS Omega; 2023 Mar; 8(11):10373-10382. PubMed ID: 36969467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Going with the µFlow: Reinterpreting Energy Input in Organic Synthesis.
    Vázquez-Amaya LY; Coppola GA; Van der Eycken EV; Sharma UK
    Chimia (Aarau); 2023 May; 77(5):327-338. PubMed ID: 38047829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microflow chemistry and its electrification for sustainable chemical manufacturing.
    Chen TY; Hsiao YW; Baker-Fales M; Cameli F; Dimitrakellis P; Vlachos DG
    Chem Sci; 2022 Sep; 13(36):10644-10685. PubMed ID: 36320706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroorganic Synthesis under Flow Conditions.
    Elsherbini M; Wirth T
    Acc Chem Res; 2019 Dec; 52(12):3287-3296. PubMed ID: 31693339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-accelerated azide-alkyne cycloaddition: micro capillary versus autoclave reactor performance.
    Borukhova S; Seeger AD; Noël T; Wang Q; Busch M; Hessel V
    ChemSusChem; 2015 Feb; 8(3):504-12. PubMed ID: 25522301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Concept of Chemical Generators: On-Site On-Demand Production of Hazardous Reagents in Continuous Flow.
    Dallinger D; Gutmann B; Kappe CO
    Acc Chem Res; 2020 Jul; 53(7):1330-1341. PubMed ID: 32543830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial.
    Jonker DJ; Nott L; Yoshino T; Gill S; Shapiro J; Ohtsu A; Zalcberg J; Vickers MM; Wei AC; Gao Y; Tebbutt NC; Markman B; Price T; Esaki T; Koski S; Hitron M; Li W; Li Y; Magoski NM; Li CJ; Simes J; Tu D; O'Callaghan CJ
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):263-270. PubMed ID: 29397354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial.
    Bekaii-Saab T; Okusaka T; Goldstein D; Oh DY; Ueno M; Ioka T; Fang W; Anderson EC; Noel MS; Reni M; Choi HJ; Goldberg JS; Oh SC; Li CP; Tabernero J; Li J; Foos E; Oh C; Van Cutsem E
    EClinicalMedicine; 2023 Apr; 58():101897. PubMed ID: 36969338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microstructured reactors as tools for the intensification of pharmaceutical reactions and processes.
    Chin P; Barney WS; Pindzola BA
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):848-61. PubMed ID: 19894194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.
    Taniguchi H; Masuishi T; Kawazoe A; Muro K; Kadowaki S; Bando H; Iino S; Kageyama R; Yoshino T
    Int J Clin Oncol; 2021 Nov; 26(11):2017-2024. PubMed ID: 34291369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scale-up Design of a Fluorescent Fluid Photochemical Microreactor by 3D Printing.
    Zhu Z; Yang L; Yu Y; Zhang L; Tao S
    ACS Omega; 2020 Apr; 5(13):7666-7674. PubMed ID: 32280910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory of chirality in a room temperature flow electrochemical reactor.
    Hardwick T; Cicala R; Wirth T; Ahmed N
    Sci Rep; 2020 Oct; 10(1):16627. PubMed ID: 33024244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodology and application of process analytical technology (PAT) for traditional Chinese medicine manufacturing:a review].
    Xiong HS; Zhang Q; Zhang SN; Cai JY; Su J; Zhu YH; Yan KJ
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):22-29. PubMed ID: 36725254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
    Shah MA; Yoshino T; Tebbutt NC; Grothey A; Tabernero J; Xu RH; Cervantes A; Oh SC; Yamaguchi K; Fakih M; Falcone A; Wu C; Chiu VK; Tomasek J; Bendell J; Fontaine M; Hitron M; Xu B; Taieb J; Van Cutsem E
    Clin Colorectal Cancer; 2023 Mar; 22(1):100-110. PubMed ID: 36503738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer.
    Nagaraju GP; Farran B; Farren M; Chalikonda G; Wu C; Lesinski GB; El-Rayes BF
    Cancer; 2020 Jul; 126(14):3360-3371. PubMed ID: 32383803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular Chemistry in Microflow Fields: Toward a New Material World of Precise Kinetic Control.
    Numata M
    Chem Asian J; 2015 Dec; 10(12):2574-88. PubMed ID: 26288064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical achievements on biomass steam gasification in a rotary tubular coiled-downdraft reactor.
    Andrew R; Gokak DT; Sharma P; Gupta S
    Waste Manag Res; 2016 Dec; 34(12):1268-1274. PubMed ID: 27495911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death.
    Froeling FEM; Swamynathan MM; Deschênes A; Chio IIC; Brosnan E; Yao MA; Alagesan P; Lucito M; Li J; Chang AY; Trotman LC; Belleau P; Park Y; Rogoff HA; Watson JD; Tuveson DA
    Clin Cancer Res; 2019 Dec; 25(23):7162-7174. PubMed ID: 31527169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor.
    Hubbard JM; Grothey A
    Drugs; 2017 Jul; 77(10):1091-1103. PubMed ID: 28573435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.